Overview

Topiramate Bioequivalence Study Brazil - Fast

Status:
Completed

Trial end date:
2011-09-11

Target enrollment:

Participant gender:

Summary

This study is prospective, open-label, randomized, crossover, single dose, with 02 treatments, 02 sequences and 02 periods. The volunteers received, in each period, the reference or the test formulation, according to the randomization list, under fasting conditions, in order to evaluate if the reference and test formulations are bioequivalent.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Topiramate